PP_1170x120_10-25-21

Atovaquone Oral Suspension USP

Lupin launches generic atovaquone oral suspension USP

Lupin launches generic atovaquone oral suspension USP

MUMBAI, India and BALTIMORE, Md. — Pharma major Lupin announced the launch of atovaquone oral suspension USP, 750 mg/5 mL having received an approval from the United States Food and Drug Administration earlier. Lupin’s atovaquone oral suspension USP, 750 mg/5 mL is the generic equivalent of Glaxosmithkline’s Mepron oral suspension 750 mg/5 mL. It is